Currently, the share price for Cohance Lifesciences Ltd. is delayed. Login to view live prices.
Cohance Lifesciences Ltd.
₹1,009.30
NSE
-- ( -- %) 1D
- Prev. Close1,009.30
- Upper Circuit1,205.40
- Lower Circuit803.60
Analyst Sentiment For Cohance Lifesciences Ltd.
As recommended by 6 analysts
Returns
Cohance Lifesciences Ltd.'s Info & Management
Suven Pharmaceuticals is a bio-pharmaceutical company, with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
- Chief Executive OfficerDr Sudhir Kumar Singh
- Chief Financial OfficerMr Himanshu Agarwal
- Chief Human Resources OfficerMr Gaurav Narain Bahadur
- Chief Strategy OfficerMr Subba Raju Komaravolu
- Senior Vice PresidentE Esakki Ramkumar
- Vice PresidentSingi Venkat Subba Reddy
FAQs on Cohance Lifesciences Ltd.
What is the share price of Cohance Lifesciences Ltd.?
Cohance Lifesciences Ltd. share price is ₹1,005.80 as of June 13, 2025, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).
What is the 52-week high and low of Cohance Lifesciences Ltd.?
The 52-week high and low of Cohance Lifesciences Ltd. is ₹1,360.00 and ₹656.00 respectively as of June 13, 2025, 03:29 PM.
52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).
What are the Upper Circuit and Lower Circuit of Cohance Lifesciences Ltd.?
The Upper Circuit of Cohance Lifesciences Ltd. is ₹1,205.
The Lower Circuit of Cohance Lifesciences Ltd. is ₹804.
What is the ROE of Cohance Lifesciences Ltd.?
Cohance Lifesciences Ltd. reported an ROE of 14.30% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.
What is the shareholding pattern of Cohance Lifesciences Ltd.?
Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Cohance Lifesciences Ltd., Promoter held 50.1%, the FII held 11%, DII held 16.7% and the public held 22.2% of the total shares.
How to buy Cohance Lifesciences Ltd. Share?
You can easily buy shares of Cohance Lifesciences Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.
What is the fair value of Cohance Lifesciences Ltd.?
The fair value of Cohance Lifesciences Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer